Hemogenyx Pharmaceuticals Statistics
Total Valuation
HOPHF has a market cap or net worth of 78.80 million. The enterprise value is 81.43 million.
| Market Cap | 78.80M |
| Enterprise Value | 81.43M |
Important Dates
The next estimated earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 4.59M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +15.82% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 14.39% |
| Owned by Institutions (%) | 55.60% |
| Float | 4.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -105.26 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.61 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -10.63 |
Financial Position
The company has a current ratio of 0.43
| Current Ratio | 0.43 |
| Quick Ratio | 0.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.39 |
| Interest Coverage | -20.88 |
Financial Efficiency
Return on equity (ROE) is -631.11% and return on invested capital (ROIC) is -87.28%.
| Return on Equity (ROE) | -631.11% |
| Return on Assets (ROA) | -70.68% |
| Return on Invested Capital (ROIC) | -87.28% |
| Return on Capital Employed (ROCE) | -293.06% |
| Weighted Average Cost of Capital (WACC) | 11.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -668,801 |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.44% in the last 52 weeks. The beta is 1.41, so HOPHF's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | -85.44% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 38.12 |
| Average Volume (20 Days) | 422 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.14M |
| Pretax Income | -10.71M |
| Net Income | -10.70M |
| EBITDA | -6.83M |
| EBIT | -7.14M |
| Earnings Per Share (EPS) | -3.03 |
Balance Sheet
The company has 310,627 in cash and 3.02 million in debt, with a net cash position of -2.71 million.
| Cash & Cash Equivalents | 310,627 |
| Total Debt | 3.02M |
| Net Cash | -2.71M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -748,611 |
| Book Value Per Share | -0.15 |
| Working Capital | -1.03M |
Cash Flow
In the last 12 months, operating cash flow was -7.63 million and capital expenditures -23,573, giving a free cash flow of -7.66 million.
| Operating Cash Flow | -7.63M |
| Capital Expenditures | -23,573 |
| Free Cash Flow | -7.66M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HOPHF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.82% |
| Shareholder Yield | -15.82% |
| Earnings Yield | -13.58% |
| FCF Yield | -9.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 13, 2024. It was a reverse split with a ratio of 0.0025.
| Last Split Date | Dec 13, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0025 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |